The inaugural MQPH 2018 Conference will take place at Keble College, Oxford from 23 – 28 September 2018, and will bring together people from a diversity of sectors. There has never been an opportunity for the diverse stakeholders involved in medicine quality and drug regulation to come together before – within the framework of a specific academic conference – to share ideas and expertise, and to outline the coordinated steps that need to be taken to tackle the problem on an international scale. Please submit your abstract by 1 June 2018.
The Oxford Senior Executive Programme in Global Health aims to provide participants with cutting edge research updates delivered by world-renowned researchers in the field of global health. 3 - 9 September 2018 at Exeter College. The programme will be structured with discussions around the opportunities for and challenges in generating relevant evidence, synthesizing existing evidence, using evidence to inform policy, implementing complex interventions and evaluating such interventions
Indonesia is a very populous country with a huge burden of infectious diseases such as TB, malaria, HIV and CNS infections. Running clinical trials requires high levels of expertise, currently developed and strengthened by institutions such as IOCRL (Universities of Indonesia and Oxford Clinical Research laboratory). Better collaborations will also help great ideas make a bigger impact.
The Antibiotics and Activity Spaces project is a survey of 4,800 villagers in Thailand and Lao PDR to better understand how people access healthcare and whether there are simple early warning indicators to detect 'problematic' antibiotic use. Marco J Haenssgen and colleagues recently hosted a photography exhibition in Bangkok on rare and vivid narratives of healing in Northern Thailand.
Professor Keith Channon will be replaced as Director of the Oxford BRC by Professor Helen McShane, of the Jenner Institute. Prof McShane said “It is a great honour to have been appointed to lead the Oxford BRC and am very excited about taking up this pivotal role for medical research in Oxford".
Disease processes can switch genes on or off in a cell and this can alter the progress of the disease. In studying the control of immune genes, Chris O’Callaghan and colleagues have discovered a new form of regulation in human genes—interacting control elements within an individual gene can flip the switch on the gene in the opposite direction to that expected.